Comment on

• Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.

  Ärnlöv J, Carlsson AC, Sundström J, Ingelsson E, Larsson A, Lind L, Larsson TE. Ärnlöv J, et al. Kidney Int. 2013 Jan;83(1):160-6. doi: 10.1038/ki.2012.327. Epub 2012 Sep 5. Kidney Int. 2013. PMID: 22951890
• Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community.

  Ratanapo S, Srivali N, Kittanamongkolchai W, Leeaphorn N, Ahmed S, Cheungpasitporn W, Chongnarungsin D. Ratanapo S, et al. Kidney Int. 2013 Sep;84(3):621. doi: 10.1038/ki.2013.238. Kidney Int. 2013. PMID: 23989361 No abstract available.